These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 21274381)

  • 1. Evaluation of Cladribine treatment in refractory celiac disease type II.
    Tack GJ; Verbeek WH; Al-Toma A; Kuik DJ; Schreurs MW; Visser O; Mulder CJ
    World J Gastroenterol; 2011 Jan; 17(4):506-13. PubMed ID: 21274381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cladribine therapy in refractory celiac disease with aberrant T cells.
    Al-Toma A; Goerres MS; Meijer JW; von Blomberg BM; Wahab PJ; Kerckhaert JA; Mulder CJ
    Clin Gastroenterol Hepatol; 2006 Nov; 4(11):1322-7; quiz 1300. PubMed ID: 16979946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Auto-SCT in refractory celiac disease type II patients unresponsive to cladribine therapy.
    Tack GJ; Wondergem MJ; Al-Toma A; Verbeek WH; Schmittel A; Machado MV; Perri F; Ossenkoppele GJ; Huijgens PC; Schreurs MW; Mulder CJ; Visser OJ
    Bone Marrow Transplant; 2011 Jun; 46(6):840-6. PubMed ID: 20818442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monitoring nonresponsive patients who have celiac disease.
    Krauss N; Schuppan D
    Gastrointest Endosc Clin N Am; 2006 Apr; 16(2):317-27. PubMed ID: 16644460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical staging and survival in refractory celiac disease: a single center experience.
    Rubio-Tapia A; Kelly DG; Lahr BD; Dogan A; Wu TT; Murray JA
    Gastroenterology; 2009 Jan; 136(1):99-107; quiz 352-3. PubMed ID: 18996383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survival in refractory coeliac disease and enteropathy-associated T-cell lymphoma: retrospective evaluation of single-centre experience.
    Al-Toma A; Verbeek WH; Hadithi M; von Blomberg BM; Mulder CJ
    Gut; 2007 Oct; 56(10):1373-8. PubMed ID: 17470479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Intracellular Intensity of CD3 on Aberrant Intraepithelial Lymphocytes Is a Prognostic Factor of the Progression to Overt Lymphoma in Refractory Celiac Disease Type II (Pre-Enteropathy-Associated T Cell Lymphoma).
    García-Hoz C; Crespo L; Lopez N; De Andrés A; Ríos León R; Santón A; Garriga M; Butz E; León F; Roy Ariño G
    Dig Dis; 2020; 38(6):490-499. PubMed ID: 32015237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of clonal refractory celiac disease or cryptic intraepithelial lymphoma: A long road from bench to bedside.
    Cellier C; Cerf-Bensussan N
    Clin Gastroenterol Hepatol; 2006 Nov; 4(11):1320-1. PubMed ID: 17110301
    [No Abstract]   [Full Text] [Related]  

  • 9. Recognising and Managing Refractory Coeliac Disease: A Tertiary Centre Experience.
    Nasr I; Nasr I; Beyers C; Chang F; Donnelly S; Ciclitira PJ
    Nutrients; 2015 Dec; 7(12):9896-907. PubMed ID: 26633478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiologic and therapeutic aspects of refractory coeliac disease - a systematic review.
    Rowinski SA; Christensen E
    Dan Med J; 2016 Dec; 63(12):. PubMed ID: 27910801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Azathioprine and prednisone combination therapy in refractory coeliac disease.
    Goerres MS; Meijer JW; Wahab PJ; Kerckhaert JA; Groenen PJ; Van Krieken JH; Mulder CJ
    Aliment Pharmacol Ther; 2003 Sep; 18(5):487-94. PubMed ID: 12950421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human leukocyte antigen-DQ2 homozygosity and the development of refractory celiac disease and enteropathy-associated T-cell lymphoma.
    Al-Toma A; Goerres MS; Meijer JW; Peña AS; Crusius JB; Mulder CJ
    Clin Gastroenterol Hepatol; 2006 Mar; 4(3):315-9. PubMed ID: 16527694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Flow cytometric determination of aberrant intra-epithelial lymphocytes predicts T-cell lymphoma development more accurately than T-cell clonality analysis in Refractory Celiac Disease.
    Verbeek WH; Goerres MS; von Blomberg BM; Oudejans JJ; Scholten PE; Hadithi M; Al-Toma A; Schreurs MW; Mulder CJ
    Clin Immunol; 2008 Jan; 126(1):48-56. PubMed ID: 18024205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathogenesis of Enteropathy-Associated T Cell Lymphoma.
    Chander U; Leeman-Neill RJ; Bhagat G
    Curr Hematol Malig Rep; 2018 Aug; 13(4):308-317. PubMed ID: 29943210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymphoma development and survival in refractory coeliac disease type II: Histological response as prognostic factor.
    Nijeboer P; van Wanrooij R; van Gils T; Wierdsma NJ; Tack GJ; Witte BI; Bontkes HJ; Visser O; Mulder C; Bouma G
    United European Gastroenterol J; 2017 Mar; 5(2):208-217. PubMed ID: 28344788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cladribine combined with rituximab (R-2-CdA) therapy is an effective salvage therapy in relapsed or refractory indolent B-cell non-Hodgkin lymphoma.
    Nagai H; Ogura M; Kusumoto S; Takahashi N; Yamaguchi M; Takayama N; Kinoshita T; Motoji T; Ohyashiki K; Kosugi H; Matsuda S; Ohnishi K; Omachi K; Hotta T
    Eur J Haematol; 2011 Feb; 86(2):117-23. PubMed ID: 21070370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 18F-FDG PET versus CT for the detection of enteropathy-associated T-cell lymphoma in refractory celiac disease.
    Hadithi M; Mallant M; Oudejans J; van Waesberghe JH; Mulder CJ; Comans EF
    J Nucl Med; 2006 Oct; 47(10):1622-7. PubMed ID: 17015897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase II study of cladribine (2-chlorodeoxyadenosine) in relapsed or refractory adult T-cell leukemia-lymphoma.
    Tobinai K; Uike N; Saburi Y; Chou T; Etoh T; Masuda M; Kawano F; Matsuoka M; Taguchi H; Makino T; Asano Y; Tamura K; Ohashi Y;
    Int J Hematol; 2003 Jun; 77(5):512-7. PubMed ID: 12841391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The MYO9B gene is a strong risk factor for developing refractory celiac disease.
    Wolters VM; Verbeek WH; Zhernakova A; Onland-Moret C; Schreurs MW; Monsuur AJ; Verduijn W; Wijmenga C; Mulder CJ
    Clin Gastroenterol Hepatol; 2007 Dec; 5(12):1399-405, 1405.e1-2. PubMed ID: 17967566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 2-chlorodeoxyadenosine (cladribine) in the treatment of hairy cell leukemia and hairy cell leukemia variant: 7-year experience in Poland.
    Robak T; Błasińska-Morawiec M; Błoński J; Hellmann A; Hałaburda K; Konopka L; Kotlarek-Haus S; Potoczek S; Hansz J; Dmoszyńska A; Urasiński I; Zdziarska B; Dwilewicz-Trojaczek J; Hołowiecki J; Skotnicki AB
    Eur J Haematol; 1999 Jan; 62(1):49-56. PubMed ID: 9918312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.